- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02661412
Immediate Loading of Implants in the Partially or Completely Edentulous Jaw (IMLOAD)
Study Overview
Status
Conditions
Detailed Description
Since its introduction in the late 1990s, immediate implant loading concepts (IL) have become a frequent alternative for delayed implant procedures. IL concepts reduce chair time, the number of surgical interventions and pain, and offer instant comfort to the patient. Its reduced treatment time results in obvious socioeconomic advantages. Although there is at present abundant evidence that supports IL, evaluation of long-term biological and mechanical stability outcomes of large patient populations could allow quality improvement and more accurate patient selection. The Departments of Oral and Maxillofacial Surgery and the Department of Dentistry of the General Hospital Saint-John Bruges act as one of the pioneers of IL in Belgium, routinely performing the concept since 2001.
The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bruges, Belgium
- General Hospital Saint-John Bruges
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients of all ages
- patients of all genders
- patients with partially or complete edentulous jaw
- patients treated at the department between 01/01/2001 and 31/12/2015
Exclusion Criteria:
- patients not eligible according to abovementioned criteria
- patients who required horizontal bone augmentation procedures of the complete alveolar bone
- patients who required a jaw reconstruction after tumor resection, osteoradionecrosis or medication-related osteonecrosis of the jaw
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
implant survival rate
Time Frame: within 6 months post placement of implants
|
Percentage of people in the study for which implant is still present of the fixture in the oral cavity
|
within 6 months post placement of implants
|
implant survival rate
Time Frame: until a maximum of 15 years of follow-up
|
Percentage of people in the study for which implant is still present of the fixture in the oral cavity
|
until a maximum of 15 years of follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infection rate
Time Frame: within 6 months post placement of implants
|
Percentage of people in the study that develop an infection at the site of the implant in the oral cavity
|
within 6 months post placement of implants
|
Infection rate
Time Frame: until a maximum of 15 years of follow-up
|
Percentage of people in the study that develop an infection at the site of the implant in the oral cavity
|
until a maximum of 15 years of follow-up
|
correlation between patient-mediated factors and occurrence of implant instability
Time Frame: within 6 months post placement of implants
|
correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon
|
within 6 months post placement of implants
|
correlation between patient-mediated factors and occurrence of implant instability
Time Frame: until a maximum of 15 years of follow-up
|
correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon
|
until a maximum of 15 years of follow-up
|
correlation between clinical factors and the occurrence of implant instability
Time Frame: within 6 months post placement of implants
|
correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon
|
within 6 months post placement of implants
|
correlation between clinical factors and the occurrence of implant instability
Time Frame: until a maximum of 15 years of follow-up
|
correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon
|
until a maximum of 15 years of follow-up
|
correlation between implant characteristics and occurrence of implant instability
Time Frame: within 6 months post placement of implants
|
correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon
|
within 6 months post placement of implants
|
correlation between implant characteristics and occurrence of implant instability
Time Frame: until a maximum of 15 years of follow-up
|
correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon
|
until a maximum of 15 years of follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Johan Abeloos, MD, division of maxillofacial surgery, department of surgery, general hospital Saint-John Bruges
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B049201627038
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Jaw, Edentulous, Partially
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
University of Alabama at BirminghamZimmer DentalCompleted
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Institut Straumann AGCompletedJaw, Edentulous, Partially | Jaw, EdentulousBelgium
-
Dentsply Sirona Implants and ConsumablesCompletedJaw, Edentulous, PartiallyUnited States, Germany
-
NeodentActive, not recruiting
-
University of MichiganTerminatedJaw, Edentulous, PartiallyUnited States